The University of Colorado Anschutz Medical Campus has been designated an Age-Friendly University for its leadership in research, education and care for older adults. The recognition is part of an international effort endorsed by the Academy for Gerontology in Higher Education (AGHE) to create more programs, policies and opportunities for an aging population.
Dr. Ginde played a major role in the design and oversight of a large trial testing whether IV Remdesivir (an inhibitor of SARS-CoV-2 that is used in hospitalized patients) might prevent subsequent hospitalization for high-risk patients with COVID-19.
In 2018, a single-center randomized trial suggested that clinicians should routinely change their approach to airway management to use a bougie (long, thin, introducer aid) when intubating. Led by Drs. Trent and Ginde, and by Michelle Howell, RN, CU was one of the most robust contributors of data.
The Multi-Center IVY Network (led at CU by Adit Ginde) recently showed dramatic decreases in COVID disease severity for people with breakthrough infections (symptomatic disease after COVID vaccination) relative to unvaccinated patients. The results were significant across a wide array of patient characteristics, and time from vaccination.